John Gilday
Mara Labs
John Gilday is associated with Mara Labs and has a research background in organic chemistry. His peer-reviewed publications focus on synthetic organic chemistry, including asymmetric synthesis, organolithium-mediated reactions, and the chemical synthesis of nitrogen-containing heterocycles such as aziridines, piperidines, and sparteine derivatives.
26 claims checked on air: 1 context 4 contradicted 6 overstated 11 supported 4 unverified
What they said on air - supported
The estrogen metabolite 4-hydroxyestrone can form DNA adducts and is genotoxic.
"one of those pathways, 4-hydroxyestrone, can be a DNA adduct. So it's it's genotoxic." (said at 0:03:36)
4-Hydroxyestrone is a catechol estrogen metabolite that undergoes metabolic oxidation to reactive catechol estrogen-3,4-quinones. These reactive electrophiles react directly with DNA bases (primarily purines like adenine and guanine) to form depurinating DNA adducts, leading to apurinic sites, mutations, and genotoxicity.
Loss of estrogen leads to loss of NRF2 induction, SIRT1 activation, and AMPK activation.
"And then as you lose this protective function, um you know, some of these other pathways that come into play are really important like NRF2. You lose NRF2 induction, um you lose SIRT1 activation, um uh AMPK as well." (said at 0:05:00)
Preclinical models of estrogen deficiency (such as ovariectomy) and translational human tissue studies demonstrate that the loss of estrogen signaling impairs the activation and downstream pathways of NRF2, SIRT1, and AMPK. Conversely, administration of estradiol or estrogen receptor agonists restores NRF2 nuclear translocation and antioxidant expression, upregulates SIRT1, and increases AMPK phosphorylation.
- supports: GPER activation attenuates cardiac dysfunction by upregulating the SIRT1/3-AMPK-UCP2 pathw… (PloS one 2023) · cited 12x in the literature
"The findings showed that T2D led to left ventricular dysfunction and signs of oxidative stress in the myocardium, which were accompanied by decreased protein levels of Sirt1/2/3/6, p-AMPK, and UCP2 in the heart. Moreover, the induction of the menopausal state exacerbated these changes. In contrast, treatment with G-1 ameliorated the hemodynamic changes associated with ovariectomy by increasing Sirt1/3, p-AMPK, UCP2, and improving oxidative status." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Impaired PGC-1α-pAMPK signaling in postmenopausal women undergoing cardiac surgery and the… (Journal of molecular and cellular cardiology plus 2025)
"Molecular analysis of atrial tissue revealed that men demonstrated increased postoperative PGC-1α and phosphorylated AMP-activated protein kinase (pAMPK), while women had reduced expression and also displayed a significant decline in myocardial NAD + levels. To mechanistically model these findings, ovariectomized mice on a high-fat diet exhibited reduced myocardial PGC-1α and pAMPK expression, suppressed antioxidant defenses, and increased fibrosis." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Estradiol and Raloxifene Protect Ovariectomized Mice from Acute Kidney Injury via G Protei… (International journal of molecular sciences 2026) · cited 1x in the literature
"E2 and RAL improved renal function and histology, reduced inflammation and oxidative stress, restored GPER expression, increased nuclear Nrf2, and upregulated HO-1 and NAD(P)H:quinone oxidoreductase 1 (NQO1). Co-treatment with ML385 or G15 reversed RAL's benefits, reduced nuclear Nrf2, and worsened injury; E2 and RAL exert renoprotective effects against OVX-related renal IRI in a manner consistent with GPER-dependent Nrf2 nuclear translocation" (abstract, results, passage verified)
pubmedfull study (doi)
SIRT1 is a histone deacetylase that functions in genome gatekeeping and participates in repairing double-stranded DNA breaks.
"SIRT1 is is a genome gatekeeper. And so, if you're if you get double-stranded breaks in your in your um in your DNA, um SIRT1 is part of the complex that goes and repairs those that DNA. ... It's a histone deacetylase." (said at 0:07:11)
SIRT1 is well established as an NAD(+)-dependent class III histone deacetylase that plays a crucial role in maintaining genomic stability and facilitating the repair of DNA double-strand breaks (DSBs). In response to DNA damage, SIRT1 is recruited to DSB sites and promotes repair through pathways including homologous recombination (HR) and non-homologous end joining (NHEJ). Because evidence for this molecular mechanism comes from cell culture and animal experimental models, the certainty of evidence under standard clinical GRADE criteria is very low.
AMP kinase acts as a metabolic sensor measuring AMP to ATP ratios and triggers mitophagy and autophagy.
"And then AMP kinase is a metabolic sensor. So it it measures the amount of AMP to ATP. So when you're running out of energy, it turns on a bunch of pathways to to clean up shop, to start reusing some of the broken parts around your garage and start making a good car again. So that's this meta- mitophagy, autophagy." (said at 0:07:50)
The speaker's statement is supported. AMP-activated protein kinase (AMPK) is a well-established cellular energy sensor that is allosterically activated by rising AMP:ATP (and ADP:ATP) ratios during energy depletion. Upon activation, AMPK promotes cellular quality control by directly activating ULK1 and inhibiting mTORC1, thereby inducing both general macroautophagy and mitochondrial-specific autophagy (mitophagy) to recycle damaged components and restore energetic homeostasis.
NRF2 induction promotes the sealing of tight junctions in enterocytes, reducing endotoxin translocation and inflammation.
"if you study um tight junctions at all, um a central feature of that, and you can read it in any review, is that NRF2 induction causes tight junctions to seal. And so, as soon as you get the tight junctions in your enterocytes sealed, you've just established the stage one of of lowering inflammation." (said at 0:24:44)
Preclinical in vitro and animal models support the claim that Nrf2 activation promotes intestinal tight junction integrity (upregulating tight junction proteins such as ZO-1, occludin, and claudins) and attenuates mucosal inflammation and barrier permeability. Genetic silencing or knockdown of Nrf2 abolishes these protective effects on epithelial barrier integrity. However, this evidence is derived entirely from cellular and rodent experimental models, meaning clinical certainty in humans remains very low.
- supports: Resveratrol attenuates intestinal epithelial barrier dysfunction via Nrf2/HO-1 pathway in … (Immunity, inflammation and disease 2024) · cited 24x in the literature
"It enhanced TEER values and upregulated TJ protein expression (ZO-1 and Occludin)... Significantly, Res augmented Nrf2 and heme oxygenase 1 (HO-1) protein levels, counteracting oxidative stress in the IECs barrier dysfunction model. Overall, our findings suggested that Res ameliorated DSS-induced IECs barrier dysfunction by activating Nrf2/HO-1 pathway" (abstract, results)
pubmedfull study (doi) - supports: Apigenin Alleviates Intestinal Ischemia/Reperfusion Injury via Upregulating Nrf2-Mediated … (Molecular nutrition & food research 2025) · cited 8x in the literature
"Apigenin up-regulated the protein expression of Nrf2, HO-1, and tight junction (TJ) proteins (p < 0.01). Furthermore, the knockdown of Nrf2 significantly abrogated apigenin-enhanced the TJ expression. Apigenin pretreatment alleviates intestinal I/R-induced barrier damage through Nrf2 activation and TJ upregulation" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Rosmarinic acid improves intestinal barrier integrity through PI3K/AKT/Nrf2-mediated regul… (International immunopharmacology 2025) · cited 9x in the literature
"RA restored intestinal barrier integrity via upregulation of key tight junction proteins such as ZO-1, occludin, claudin-1 in colonic tissues. Mechanistic analyses in lipopolysaccharide (LPS)-stimulated NCM460 human colonic epithelial cells revealed that RA inhibited phosphatidylinositol 3-kinase (PI3K)/AKT pathway activation, as evidenced by reducing AKT phosphorylation (p-AKT), while enhancing nuclear factor erythroid 2-related factor 2 (Nrf2) expression. Pharmacological PI3K inhibition with LY294002 abolished RA-induced upregulation of Nrf2 and TJPs" (abstract, results, passage verified)
pubmedfull study (doi)
Pure sulforaphane induces cell death and apoptosis in cell cultures at concentrations of approximately 10 micromolar.
"there's some papers out there showing sulforaphane has some um apoptosis induction, you know, at like 10 micromol, you know... if you order sulforaphane from Sigma where it's 100% sulforaphane, it does start showing cell death at 10 micromol." (said at 0:45:00)
In vitro studies evaluating sulforaphane in cell cultures demonstrate that concentrations around 10 to 30 μM induce cell cycle arrest, inhibition of cell proliferation, reactive oxygen species generation, and apoptotic cell death across various cell lines. Because this evidence is derived exclusively from in vitro cell culture models, certainty for broader biological/in vivo implications is rated very low.
Sulforaphane activates the lysosomal receptor mucolipin 1 (TRPML1) through a redox-sensitive cysteine, releasing calcium and triggering lysosomal exocytosis via a synaptotagmin complex and LAMP-2.
"it's through a receptor called mucolipin 1. And so it has a redox sensitive cysteine that's just the same as what I was talking about earlier about on Keap1 and on IKKβ for NF-κB pathway. So this is in actually in the lysosome membrane and when you activate that you release calcium from the uh lysosome and it initiates a signaling cascade where um the same the same pathway where you get um neurotransmitters dumped in into uh the synaptic cleft in your brain. Um it's for neurotransmission. It's a synaptotagmin complex and LAMP-2. It fuses with the cell surface and actually um releases the lysosome right into the extracellular space." (said at 1:07:40)
Preclinical in vitro research demonstrates that sulforaphane (SFN) acts on the lysosomal cation channel mucolipin 1 (MCOLN1/TRPML1) through redox-sensitive mechanisms, promoting lysosomal calcium (Ca2+) release. This calcium signaling engages the machinery involved in lysosomal exocytosis and trafficking (including synaptotagmin complexes and lysosomal-associated membrane proteins) and triggers downstream pathways such as TFEB activation. Because this mechanism has only been demonstrated in cell culture and animal models, certainty is graded as very low.
TFEB is the master transcription factor that regulates lysosome biogenesis.
"there's a master transcription factor that regulates lysosome production. It's called TFEB" (said at 1:09:30)
Published cell biology research establishes transcription factor EB (TFEB) as the master transcription factor coordinating lysosomal biogenesis and autophagy. TFEB binds Coordinated Lysosomal Expression and Regulation (CLEAR) motifs in promoters across the lysosomal gene network, driving lysosomal biogenesis, acidification, and cellular clearance pathways.
Resveratrol induces genes regulated by TFEB to enhance lysosomal system capacity.
"resveratrol is very good at inducing this whole set of genes that are are made to make your lysosomal system a better conveyor belt." (said at 1:09:40)
Preclinical in vitro and animal studies support that resveratrol promotes the activation and nuclear translocation of transcription factor EB (TFEB)—a master transcriptional regulator of the autophagy-lysosome pathway (the CLEAR gene network)—thereby upregulating genes involved in lysosomal biogenesis, autophagosome formation, and lysosomal degradation capacity. However, evidence is currently limited to cellular and animal models, and clinical evidence in humans remains unestablished.
EGCG (epigallocatechin gallate) is an effective inhibitor of LPS-induced inflammatory stimulation.
"if people are interested in in blocking some of that is uh EGCG is one of the best inhibitors of that" (said at 1:17:48)
Published in vitro and animal studies consistently demonstrate that epigallocatechin-3-gallate (EGCG) suppresses lipopolysaccharide (LPS)-induced inflammatory activation. In cell culture (such as macrophages and dendritic cells) and rodent endotoxemia models, EGCG inhibits Toll-like receptor 4 (TLR4) signaling, attenuates NF-κB and MAPK pathway activation, and substantially reduces LPS-stimulated production of inflammatory mediators including TNF-α, IL-1β, IL-6, and inducible nitric oxide synthase. Because the available evidence relies primarily on preclinical mechanistic models, the certainty of evidence for clinical translation is very low.
- supports: Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa… (Biochemical and biophysical research communications 2012) · cited 75x in the literature
"In addition, EGCG-treated DCs inhibited lipopolysaccharide (LPS)-induced production of pro-inflammatory cytokines (tumor necrosis factor [TNF]-α, interleukin [IL]-1β, and IL-6) and activation of mitogen-activated protein kinases (MAPKs)... and nuclear factor κB (NF-κB) p65 translocation through 67LR." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by sup… (Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2019) · cited 69x in the literature
"In addition, EGCG significantly decreased the expression of pro-inflammatory cytokines tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in the lung, serum, and bronchoalveolar lavage fluid, and alleviated the expression of TLR-4, MyD88, TRIF, and p-p65 in the lung tissue." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Epigallocatechin gallate (EGCG) inhibits lipopolysaccharide-induced inflammation in RAW 26… (Food science & nutrition 2023) · cited 43x in the literature
"In LPS-induced macrophage cells, EGCG was found to lower cellular nitric oxide (32% of LPS group) and intercellular ROS level (45.4% of LPS group). It also suppressed the expression of IL-1β (LPS 132.6 ± 14.6, EGCG 10.67 ± 3.65), IL-6 (LPS 2994.44 ± 178.5, EGCG 408.33 ± 52.34), TNF-α (LPS 27.11 ± 2.84, EGCG 1.22 ± 0.03), and iNOS (LPS 40.45 ± 11.17, EGCG 10.24 ± 0.89)." (abstract, results, passage verified)
pubmedfull study (doi)
Carnosic acid functions as a mild Nrf2 inducer, mild NF-κB inhibitor, and mild AMPK activator.
"carnosic acid is one of these molecules that I've been looking at for a long time because it can work synergistically with a lot of the ones that we already have now. So, it has very broad activity. It's a uh a mild NRF2 inducer, mild NF-κB inhibitor, and and mild AMPK kinase activator." (said at 1:19:50)
Preclinical studies (in vitro and animal models) support the characterization of carnosic acid—a major phenolic diterpene found in rosemary—as an agent that activates the Nrf2 antioxidant response pathway, inhibits NF-κB inflammatory signaling, and activates AMP-activated protein kinase (AMPK). Because available evidence is limited to cell culture and animal studies, overall certainty is very low.
- supports: Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB… (Phytomedicine : international journal of phytotherapy and phytopharmacology 2018) · cited 54x in the literature
"The results showed that CA activated Nrf2, inhibited NF-κB pathway and regulated related downstream genes in mGMC under HG condition." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Carnosic Acid and Carnosol Activate AMPK, Suppress Expressions of Gluconeogenic and Lipoge… (International journal of molecular sciences 2021) · cited 41x in the literature
"This study showed that both CA and CL, but not RA, induce significant phosphorylation of AMP-dependent kinase (AMPK) and its downstream acetyl-CoA carboxylase 1 (ACC1) in HepG2 hepatoma cells." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Anti-Inflammatory Therapeutic Mechanisms of Natural Products: Insight from Rosemary Diterp… (Biomedicines 2023) · cited 116x in the literature
"Hand in hand with these activities are their multiple biological effects and therapeutic potential orchestrated through modulating various signalling pathways of inflammation, including the NF-κB, MAPK, Nrf2, SIRT1, STAT3 and NLRP3 inflammasomes, among others." (abstract, results, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications